Pathway analysis of CD45+ TAS and CD45+ tumor epithelium differential expression revealed a number of prostate cancer related pathways including epithelial adherent molecules junction signaling, TEC kinase signaling, and HGF [54,55,56]. This evidence concerns the gene PTPRC and neoplasm.